Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20112
20121
20131
20151
20181
20221
20232
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company4
Viatris Innovation GmbH2
AstraZeneca1
Baxalta now part of Shire1
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1
Human Genome Sciences Inc.1
La Jolla Pharmaceutical Company1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases17
Lupus Erythematosus, Systemic9
Immune System Diseases8
Connective Tissue Diseases5
Lung Diseases, Interstitial2
Lupus Nephritis2
Autoimmune Diseases of the Nervous System1
Barth Syndrome1
Blood Platelet Disorders1
Cytopenia1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.